ScholarWorks@Gyeongsang National University: Browsing ScholarWorks

Browsing by Kang, E. J.Author

Showing results 1 to 3 of 3

SCIESCOPUS

A phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04)open access

Ahn, M. J.; Park, S.; Kim, T. M.; Han, J. Y.; Lee, G. W.; Shim, B.; Lee, Y. G.; Kim, S. W.; Kim, I. H.; Lee, S., et al.

ArticleIssue Date2023CitationAnnals of Oncology, v.34, pp S1311 - S1311PublisherOxford University Press

SCISCIESCOPUS

Influence of epidermal growth factor supplementation during in vitro maturation on nuclear status and gene expression of canine oocytes

Song, H. J.; Kang, E. J.; Maeng, G. H.; Ock, S. A.; Lee, S. L.; Yoo, J. G.; Jeon, B. G.; Rho, G. J.

ArticleIssue Date2011CitationRESEARCH IN VETERINARY SCIENCE, v.91, no.3, pp 439 - 445PublisherELSEVIER SCI LTD

SCIESCOPUS

Real-world evidence of first-or second-line immune checkpoint inhibitors versus chemotherapy in advanced NSCLC: A prospective pragmatic multicenter Korean study

Kim, J.; Park, S.; Lee, G- W.; Kim, I. H.; Kim, D- W.; Lee, Y- G.; Cho, J. H.; Cho, E. K.; Lee, H. W.; Park, J. H., et al.

ArticleIssue Date2025CitationAnnals of Oncology, v.36PublisherOxford University Press

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0534

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Kang, E. J.Author

BROWSE